FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称SAMOTOLISIB
异名/同义词2H-IMIDAZO(4,5-C)QUINOLIN-2-ONE, 1,3-DIHYDRO-8-(5-(1-HYDROXY-1-METHYLETHYL)-3-PYRIDINYL)-1-((2S)-2-METHOXYPROPYL)-3-METHYL-
8-(5-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((2S)-2-METHOXYPROPYL)-3-METHYL-1,3-DIHYDRO-2H-IMIDAZO(4,5-C)QUINOLIN-2-ONE
LY3023414
LY-3023414
PI3K/MTOR INHIBITOR LY3023414
SAMOTOLISIB
SAMOTOLISIB [INN]
SAMOTOLISIB [USAN]
SAMOTOLISIB [WHO-DD]
CAS登记号1386874-06-1
物质唯一标识(Unique Ingredient Identifier)C88817F47Y
分子式C23H26N4O3
国际化合物标识(International Chemical Identifier,InChI)ACCFLVVUVBJNGT-AWEZNQCLSA-N
SMILESn1cc2c(c3cc(ccc13)-c4cncc(c4)C(C)(C)O)n(c(n2C)=O)C[C@H](C)OC
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System